An All-Canada COVID-19 Vaccine Solution

By Louis Garguilo, Chief Editor, Outsourced Pharma

Providence Therapeutics, a Calgary, Ontario-based, emerging mRNA biopharma, has become a focal point in a national “Canada First” initiative to develop a domestic COVID-19 vaccine.

The story of how it came to achieve such notoriety is an interesting one that includes a pivot from its core therapeutic focus, the hiring of an American as company president, and the creation of a CDMO.